BRAF and cancer: In other words, once cancer cells possess a high level of active Ras, the drug-loaded BRAF(V600E) will dimerize with CRAF and trigger its catalytic activity[28-30,32,33], which has been termed as the paradoxical effect of RAF inhibitors.